# A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

> **NCT05325008** · PHASE3 · RECRUITING · sponsor: **The University of Queensland** · enrollment: 280 (estimated)

## Conditions studied

- BK Viremia
- Kidney Transplant Infection
- Kidney Transplant Failure and Rejection

## Interventions

- **DRUG:** Immunosuppression reduction/modification + intravenous immunoglobulin
- **OTHER:** Immunosuppression reduction/modification

## Key facts

- **NCT ID:** NCT05325008
- **Lead sponsor:** The University of Queensland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-18
- **Primary completion:** 2027-08-01
- **Final completion:** 2029-06-30
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05325008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05325008, "A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05325008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*